{
  "meta": {
    "title": "67_Pulmonary_Vascular_Diseases",
    "url": "https://brainandscalpel.vercel.app/67-pulmonary-vascular-diseases-fc996b21.html",
    "scrapedAt": "2025-11-30T06:57:35.365Z"
  },
  "questions": [
    {
      "id": 83644,
      "choices": [
        {
          "id": 219019,
          "text": "pulmonary artery"
        },
        {
          "id": 219020,
          "text": "bronchial artery"
        },
        {
          "id": 219021,
          "text": "pulmonary vein"
        },
        {
          "id": 219022,
          "text": "superior venacava"
        }
      ],
      "text": "A young man with tuberculosis presents with massive recurrent hemoptysis. For angiographic treatment which vascular structure should be evaluated first",
      "unique_key": "Q7561828",
      "question_audio": null,
      "question_video": null,
      "map_id": 34432992,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Bronchial artery. In patients with tuberculosis who present with massive recurrent hemoptysis, the most likely vascular structure responsible for the bleeding is the bronchial artery. In tuberculosis, the granulomatous inflammation and cavitary lesions can lead to the erosion of blood vessels, including the bronchial arteries. These arteries supply the lungs with blood and are often the primary source of hemorrhage in cases of tuberculosis-related hemoptysis. Angiographic treatment typically involves embolizing the bronchial artery to stop the bleeding. Therefore, when performing angiography for treatment of hemoptysis in tuberculosis, the bronchial artery should be evaluated first to identify any active bleeding and to facilitate embolization. Incorrect Options: A. Pulmonary artery (incorrect): The pulmonary artery carries deoxygenated blood from the right heart to the lungs for gas exchange, but it is not typically involved in hemoptysis, particularly in tuberculosis-related cases. Hemoptysis from tuberculosis usually arises from the bronchial arteries, which supply the lung tissue. The pulmonary artery is more commonly implicated in conditions like pulmonary embolism or pulmonary hypertension, but it is not a common source of hemoptysis in the setting of tuberculosis. Therefore, this option is incorrect. C. Pulmonary vein (incorrect): The pulmonary veins carry oxygenated blood from the lungs to the left side of the heart. They are not typically involved in the process of hemoptysis. Hemoptysis due to tuberculosis usually stems from damage to the small vessels in the lung parenchyma, such as the bronchial arteries, rather than the pulmonary veins. Thus, evaluating the pulmonary veins would not be appropriate in this case, making this option incorrect. D. Superior vena cava (incorrect): The superior vena cava is a large vein that drains deoxygenated blood from the upper half of the body into the right atrium of the heart. While conditions like superior vena cava syndrome can lead to swelling or distention of veins, it is not typically associated with hemoptysis. The source of massive hemoptysis in tuberculosis is generally the bronchial arteries, not the superior vena cava. Hence, this option is incorrect.",
      "correct_choice_id": 219020,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83645,
      "choices": [
        {
          "id": 219023,
          "text": "DLCO"
        },
        {
          "id": 219024,
          "text": "CT chest"
        },
        {
          "id": 219025,
          "text": "2D Echo"
        },
        {
          "id": 219026,
          "text": "Right heart catheterisation"
        }
      ],
      "text": "Gold standard both to establish the diagnosis of Pul HTN",
      "unique_key": "Q5278018",
      "question_audio": null,
      "question_video": null,
      "map_id": 34014820,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Right heart catheterization Explanation for the correct response: The gold standard for diagnosing pulmonary hypertension (PH) is right heart catheterization. This is a direct and accurate method of measuring pulmonary artery pressures, which are crucial for the diagnosis of PH. It allows for the measurement of key parameters like pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR), which are essential for diagnosing and categorizing pulmonary hypertension. The catheterization also helps to differentiate between different types of PH (such as PH due to left heart disease, chronic lung disease, or idiopathic pulmonary arterial hypertension) based on pressure measurements, thus confirming the diagnosis. Explanation for the incorrect responses: A. DLCO (Diffusing Capacity of the Lung for Carbon Monoxide): While DLCO can be useful in assessing lung function and detecting early signs of lung diseases that can contribute to pulmonary hypertension (such as interstitial lung disease), it is not a diagnostic test for pulmonary hypertension. It does not directly measure pulmonary pressures or vascular resistance, so it cannot establish the diagnosis of PH. B. CT chest: A CT chest can be helpful in identifying causes of pulmonary hypertension, such as pulmonary embolism, lung parenchymal disease, or congenital heart defects. However, it cannot directly measure pulmonary pressures, which are needed to diagnose PH. It is more of a complementary tool in evaluating underlying causes rather than a diagnostic gold standard for PH. C. 2D Echo: 2D echocardiography is a non-invasive test that can provide an estimate of pulmonary pressures based on the tricuspid regurgitant jet velocity, but it does not directly measure the pulmonary artery pressure. It can be used for screening or as a preliminary tool to suggest the possibility of pulmonary hypertension. However, right heart catheterization is required to confirm the diagnosis and determine the severity of PH.",
      "correct_choice_id": 219026,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83646,
      "choices": [
        {
          "id": 219027,
          "text": "SLE"
        },
        {
          "id": 219028,
          "text": "RA"
        },
        {
          "id": 219029,
          "text": "Dermatomyositis"
        },
        {
          "id": 219030,
          "text": "Scleroderma"
        }
      ],
      "text": "Among CTDs PAH is commonest in which disease ?",
      "unique_key": "Q4482621",
      "question_audio": null,
      "question_video": null,
      "map_id": 34896325,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Scleroderma Explanation for the correct response: Pulmonary arterial hypertension (PAH) is most commonly associated with scleroderma (systemic sclerosis) among connective tissue diseases (CTDs). Scleroderma is a chronic autoimmune condition characterized by the thickening and fibrosis of the skin and internal organs, and it is well-known for its association with PAH. The exact mechanism behind this association is not completely understood, but it is believed to be related to vascular remodeling and endothelial dysfunction, which leads to increased pulmonary vascular resistance. In scleroderma, PAH is one of the most significant causes of morbidity and mortality. Explanation for the incorrect responses: A. SLE (Systemic Lupus Erythematosus): While systemic lupus erythematosus (SLE) can cause various forms of pulmonary involvement, including pleuritis and interstitial lung disease, PAH is relatively less common in SLE compared to scleroderma. The pathogenesis of lung disease in SLE tends to be more related to inflammation and autoimmune injury rather than the vascular changes seen in scleroderma. B. RA (Rheumatoid Arthritis): Rheumatoid arthritis (RA) can also lead to pulmonary complications such as pleural effusions, interstitial lung disease, and even PAH, but RA-associated PAH is not as common or as severe as in scleroderma. RA-related PAH is often seen in the later stages of the disease or in those with more severe disease, but it remains less prevalent compared to scleroderma. C. Dermatomyositis: Dermatomyositis is an inflammatory muscle disease that can be associated with various pulmonary manifestations, such as interstitial lung disease and aspiration pneumonia, but PAH is not a prominent feature of dermatomyositis. While there are some reports of PAH in dermatomyositis, it is not as common or as significant a complication as in scleroderma.",
      "correct_choice_id": 219030,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83647,
      "choices": [
        {
          "id": 219031,
          "text": "mPAP>25MMHG, PCWP >15 mmhg"
        },
        {
          "id": 219032,
          "text": "mPAP>25MMHG, PCWP < 15 mmhg"
        },
        {
          "id": 219033,
          "text": "mPAP>15MMHG, PCWP >25 mmhg"
        },
        {
          "id": 219034,
          "text": "mPAP< 25MMHG, PCWP <15 mmhg"
        }
      ],
      "text": "Pre capillary pulmonary hypertension is defined as",
      "unique_key": "Q9919608",
      "question_audio": null,
      "question_video": null,
      "map_id": 34896310,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) mPAP > 25 mmHg, PCWP 25 mmHg with a pulmonary capillary wedge pressure (PCWP) 25 mmHg, PCWP > 15 mmHg: This scenario suggests post-capillary pulmonary hypertension, which occurs due to left heart disease, such as left ventricular failure or mitral valve disease. In this case, the elevated mPAP is a result of elevated left heart pressures (reflected by an elevated PCWP), which is not characteristic of pre-capillary pulmonary hypertension. C. mPAP > 15 mmHg, PCWP > 25 mmHg: This option suggests an abnormal situation where both mPAP and PCWP are elevated, with a PCWP > 25 mmHg, which is more indicative of severe post-capillary pulmonary hypertension due to left-sided heart failure. It does not fit the definition of pre-capillary pulmonary hypertension. D. mPAP 25 mmHg. A normal mPAP (less than 25 mmHg) with a normal PCWP (< 15 mmHg) does not meet the criteria for any form of pulmonary hypertension.",
      "correct_choice_id": 219032,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83648,
      "choices": [
        {
          "id": 219035,
          "text": "WHO Group I"
        },
        {
          "id": 219036,
          "text": "WHO Group II"
        },
        {
          "id": 219037,
          "text": "WHO Group III"
        },
        {
          "id": 219038,
          "text": "WHO Group IV"
        }
      ],
      "text": "Most common cause of Pulmonary Hypertension",
      "unique_key": "Q1193852",
      "question_audio": null,
      "question_video": null,
      "map_id": 34598898,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) WHO Group II Explanation for the correct response: WHO Group II pulmonary hypertension is the most common cause of pulmonary hypertension and is associated with left heart disease, specifically left-sided heart failure. This includes conditions such as left ventricular dysfunction, mitral valve disease, and aortic valve disease. In this group, the pulmonary hypertension arises due to increased pressures in the left side of the heart, which then lead to pulmonary venous congestion and subsequent pulmonary arterial pressure elevation. This group accounts for the largest proportion of pulmonary hypertension cases. Explanation for the incorrect responses: A. WHO Group I: WHO Group I refers to pulmonary arterial hypertension (PAH), a rare condition that results from disease processes affecting the pulmonary arteries, such as idiopathic PAH, hereditary PAH, or PAH associated with connective tissue diseases or HIV. Although serious, this group is not the most common cause of pulmonary hypertension. C. WHO Group III: WHO Group III includes pulmonary hypertension due to chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) or interstitial lung disease. While these are significant causes of pulmonary hypertension, they are less common than left heart disease (Group II), making them less frequent overall. D. WHO Group IV: WHO Group IV includes pulmonary hypertension due to chronic thromboembolic pulmonary hypertension (CTEPH), which is caused by persistent blood clots in the lungs. Although it can lead to significant morbidity, it is still less common compared to left heart disease-related pulmonary hypertension (Group II).",
      "correct_choice_id": 219036,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83649,
      "choices": [
        {
          "id": 219039,
          "text": "Malignant pleural effusions secondary to metastatic disease are the second most common type of exudative pleural effusion"
        },
        {
          "id": 219040,
          "text": "In many parts of the world, the most common cause of an exudative pleural effusion is tuberculosis (TB)"
        },
        {
          "id": 219041,
          "text": "The pleural fluid is almost always a transudate in Pulmonary embolism"
        },
        {
          "id": 219042,
          "text": "The treatment of choice for most chylothoraxes is insertion of a chest tube plus the administration of octreotide"
        }
      ],
      "text": "All of the following are true except",
      "unique_key": "Q4293383",
      "question_audio": null,
      "question_video": null,
      "map_id": 34763947,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) The pleural fluid is almost always a transudate in pulmonary embolism. In pulmonary embolism (PE), pleural effusion can occur, but it is typically exudative, not transudative. The pleural effusion in PE is caused by inflammation due to the infarction of lung tissue, which leads to increased permeability of the pleural capillaries, resulting in an exudative effusion. Transudative effusions are more commonly seen in conditions like heart failure and cirrhosis, where fluid accumulates due to imbalances in hydrostatic or oncotic pressure, rather than inflammation or injury. Why Other Options are true: (A) Malignant pleural effusions secondary to metastatic disease are the second most common type of exudative pleural effusion: This statement is correct. Malignant pleural effusions, often due to metastasis, are one of the most common causes of exudative pleural effusion. Lung cancer, breast cancer, and other metastatic tumors can cause pleural effusions through direct tumor invasion or obstruction of lymphatic drainage. (B) In many parts of the world, the most common cause of an exudative pleural effusion is tuberculosis (TB): This is correct, especially in regions with a high prevalence of tuberculosis. TB is a leading cause of exudative pleural effusion in developing countries, where it causes parapneumonic effusion and tuberculous pleuritis, both of which lead to exudative fluid. (D) The treatment of choice for most chylothoraxes is insertion of a chest tube plus the administration of octreotide: This is correct. Chylothorax occurs due to the leakage of lymphatic fluid into the pleural space. The initial management usually includes chest tube insertion to drain the fluid. In addition, octreotide, a somatostatin analog, may be used to reduce the production of lymphatic fluid and promote closure of the lymphatic duct, especially in cases where the chylothorax is persistent or refractory.",
      "correct_choice_id": 219041,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83650,
      "choices": [
        {
          "id": 219043,
          "text": "Bronchogenic carcinoma"
        },
        {
          "id": 219044,
          "text": "Pulmonary tuberculosis"
        },
        {
          "id": 219045,
          "text": "Cryptogenic fibrosing alveolitis"
        },
        {
          "id": 219046,
          "text": "Wegener’s granulomatosis"
        }
      ],
      "text": "A 55-year-old man presents with a history of cough and massive haemoptysis of 2 weeks’ duration. Six months ago he was diagnosed with sinusitis and started on some nasal drops. His CXR shows bilateral infiltrates and nodules with cavitations. He has never smoked and works in a zoo. What is the most likely diagnosis?",
      "unique_key": "Q4644854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34979355,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Wegener’s granulomatosis (now known as Granulomatosis with polyangiitis). The patient's symptoms of cough, massive hemoptysis, bilateral infiltrates, and nodules with cavitations on chest X-ray strongly suggest a vasculitis affecting both the lungs and sinuses. Wegener's granulomatosis is a type of granulomatosis with polyangiitis (GPA), an autoimmune disorder that commonly involves the upper and lower respiratory tracts and causes symptoms like sinusitis, pulmonary infiltrates, and cavitary lesions. It is associated with the production of anti-neutrophil cytoplasmic antibodies (ANCA), particularly the c-ANCA type, and often leads to systemic symptoms due to the inflammation of small and medium-sized blood vessels. The fact that the patient works in a zoo could also raise suspicion of an infection from zoonotic pathogens, though the imaging findings and clinical history point more toward an autoimmune cause. The condition is more likely in a patient with chronic sinusitis, lung involvement (e.g., cavitating lesions), and systemic symptoms. Why the other options are incorrect: A. Bronchogenic carcinoma: Bronchogenic carcinoma is a common cause of hemoptysis, especially in smokers. However, this patient's lack of smoking history and bilateral infiltrates with nodules and cavitation on the chest X-ray make it unlikely to be bronchogenic carcinoma. Cavitary lesions in carcinoma are less commonly seen compared to granulomatous diseases like Wegener's granulomatosis. Furthermore, bronchogenic carcinoma would more likely present as a unilateral mass or consolidation rather than bilateral findings. B. Pulmonary tuberculosis: Pulmonary tuberculosis (TB) can cause hemoptysis and cavitary lesions in the lungs, but the patient's recent onset of symptoms (2 weeks) and the presence of bilateral infiltrates and nodules are less typical of TB. TB usually presents with more insidious symptoms and can be associated with night sweats, weight loss, and fever, which this patient does not report. Moreover, the patient’s history of sinusitis and working in a zoo also suggests a non-tuberculous cause of the lung pathology. C. Cryptogenic fibrosing alveolitis: Cryptogenic fibrosing alveolitis (also known as idiopathic pulmonary fibrosis) is a type of interstitial lung disease that primarily affects the lung parenchyma, leading to progressive dyspnea and fibrosis. However, it is typically insidious in onset, with slow progression and does not typically cause hemoptysis or cavitary lesions. The patient's symptoms of massive hemoptysis, bilateral infiltrates, and nodules do not match the typical presentation of fibrosing alveolitis.",
      "correct_choice_id": 219046,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83651,
      "choices": [
        {
          "id": 219047,
          "text": "Order a ventilation-perfusion (VQ) scan"
        },
        {
          "id": 219048,
          "text": "Give the patient heparin"
        },
        {
          "id": 219049,
          "text": "Move the patient to ICU and do a CT angiogram"
        },
        {
          "id": 219050,
          "text": "Perform and embolectomy"
        }
      ],
      "text": "A 40-year-old woman coming from USA just deplaned at the airport. She started feeling short of breath one hour before landing.She was brought immediately to the ED.On examination- BP: 108/68 mm Hg; P:108 beats/minute; T: 101°F; R: 24 breaths/minute. Chest: clear to auscultation, no rales, rhonchi, or crepitations, Cardiovascular: normal. Oximeter 90% room air saturation, Chest x-ray: normal ABG: pH 7.47; PCO2 31 mm Hg; PO2 62 mm Hg.What should you do next ?",
      "unique_key": "Q3745894",
      "question_audio": null,
      "question_video": null,
      "map_id": 34329963,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Give the patient heparin. This 40-year-old woman presents with acute onset shortness of breath after a long flight, which raises suspicion for pulmonary embolism (PE), particularly considering the fact that she is likely a long-distance traveler who has been sitting for a prolonged period. Although her chest x-ray is normal and her vital signs are stable, her hypoxemia (PO2 of 62 mm Hg) and tachycardia (pulse of 108 beats/minute) are concerning. The ABG results also show hypoxemia (low PO2) and respiratory alkalosis (low PCO2, likely due to compensatory hyperventilation). Given the high suspicion of PE and the patient's current status, the next step is to initiate anticoagulation with heparin while awaiting further diagnostic confirmation (such as a CT pulmonary angiogram). Heparin will help prevent further clot formation and reduce the risk of worsening the embolism. Incorrect Options: A. Order a ventilation-perfusion (VQ) scan: A V/Q scan is a useful tool for diagnosing PE, especially when a CT angiogram is not readily available or when there is a contraindication to CT contrast. However, in this patient, who is clinically stable and has a high suspicion of PE, a CT pulmonary angiogram (CTA) is typically preferred for direct visualization of the embolus. V/Q scans are usually ordered when a CTA cannot be performed or if there are contraindications to contrast agents. C. Move the patient to ICU and do a CT angiogram: While the patient should be closely monitored, there is no immediate indication for ICU admission in this case, as her vital signs are relatively stable. A CT angiogram (CTA) is an appropriate diagnostic tool to confirm the diagnosis of PE, but the immediate priority is to start anticoagulation (heparin) to prevent further clot formation. Once anticoagulated, the CTA can be done. D. Perform an embolectomy: An embolectomy is a surgical procedure typically reserved for patients with massive PE who are hemodynamically unstable and require urgent intervention to prevent death. This patient's stable condition, with normal BP and no signs of shock, does not indicate the need for embolectomy at this time. Anticoagulation is the appropriate initial therapy.",
      "correct_choice_id": 219048,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52863971705050062/52863971705050062.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52863971705050062/52863971705050062.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83652,
      "choices": [
        {
          "id": 219051,
          "text": "Lower extremity Doppler ultrasound"
        },
        {
          "id": 219052,
          "text": "Hypotension and right-sided heart strain on echocardiogram"
        },
        {
          "id": 219053,
          "text": "CT angiogram"
        },
        {
          "id": 219054,
          "text": "VQ scan and d-dimer"
        }
      ],
      "text": "In continuation with previous clinical vignette, she developed hypotension in ED and you got ECHO done in the patient which showed RV strain. How will you determine the need for thrombolytics?",
      "unique_key": "Q6101646",
      "question_audio": null,
      "question_video": null,
      "map_id": 34625591,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hypotension and right-sided heart strain on echocardiogram. The development of hypotension and right ventricular (RV) strain on echocardiogram in this patient with suspected pulmonary embolism (PE) indicates massive PE, which is a life-threatening condition. In the setting of massive PE, where there is significant hemodynamic compromise (e.g., hypotension) and evidence of right heart strain, thrombolytic therapy is considered for rapid resolution of the clot and to restore hemodynamic stability. The presence of right ventricular strain on echocardiogram is a strong indication for the use of thrombolytics, as it suggests a large PE causing significant cardiovascular collapse. Incorrect Options: A. Lower extremity Doppler ultrasound: A lower extremity Doppler ultrasound is helpful in diagnosing deep vein thrombosis (DVT), which can be a source of pulmonary embolism. However, in this patient with hypotension and right heart strain, the focus is on managing the pulmonary embolism, and further investigation of DVT is not needed to make a decision about thrombolytics. The priority is confirming the severity of the PE and starting appropriate treatment, such as thrombolysis. C. CT angiogram: A CT pulmonary angiogram (CTA) is an essential diagnostic tool for confirming pulmonary embolism, but it is not the deciding factor for whether thrombolytics should be administered. In this patient, hemodynamic instability and right ventricular strain on echocardiogram are already highly suggestive of massive PE, and thrombolysis should be considered immediately rather than waiting for a CTA result. CTA is useful for confirming the diagnosis but not necessarily for determining thrombolytic therapy in a critical patient. D. VQ scan and D-dimer: A V/Q scan and D-dimer can be helpful in the diagnosis of PE, especially in patients with low or moderate pre-test probability of PE. However, in this case, the patient is already presenting with hemodynamic instability, and the decision for thrombolysis is based on clinical findings (i.e., hypotension and RV strain). D-dimer and V/Q scan are typically used in diagnostic workup, but they are not the determining factors for initiating thrombolytic therapy.",
      "correct_choice_id": 219052,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25524351705050082/25524351705050082.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25524351705050082/25524351705050082.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83653,
      "choices": [
        {
          "id": 219055,
          "text": "Add epoprostenol"
        },
        {
          "id": 219056,
          "text": "Add sildenafil"
        },
        {
          "id": 219057,
          "text": "Add calcium channel blocker"
        },
        {
          "id": 219058,
          "text": "Add diuretics"
        }
      ],
      "text": "In continuation with previous case scenario patient underwent ECHO which showed high pulmonary artery pressure. Right heart catheterization was done and results were- mPAP(mean pulmonary artery pressure) of 30 mmHg, PCWP 12 mmHg, high pulmonary vascular resistance and no response to nitric oxide in pulmonary artery pressure. What will you advice further",
      "unique_key": "Q6396989",
      "question_audio": null,
      "question_video": null,
      "map_id": 34689067,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Add epoprostenol. The patient's right heart catheterization findings show pulmonary hypertension (PH) with a mean pulmonary artery pressure (mPAP) of 30 mmHg, which is elevated and consistent with pulmonary arterial hypertension (PAH). The lack of a response to nitric oxide in pulmonary artery pressure suggests idiopathic pulmonary arterial hypertension or PAH that is non-reversible with vasodilators like nitric oxide. In such cases, the most effective treatment is epoprostenol, a prostacyclin analog, which is a vasodilator and pulmonary vasculature relaxant. It is commonly used in severe, non-responsive cases of PAH to improve symptoms and prolong survival. Epoprostenol is administered intravenously and has been shown to significantly decrease pulmonary vascular resistance, improving exercise capacity and oxygenation. Incorrect Options: B. Add sildenafil: While sildenafil, a phosphodiesterase-5 inhibitor, is used in the treatment of pulmonary hypertension, it is typically indicated when there is some response to pulmonary vasodilators or in cases where oral agents are needed. In this patient, since there was no response to nitric oxide, epoprostenol is a better choice for severe, non-responsive pulmonary hypertension. Sildenafil is often used for milder cases or as add-on therapy, but it is not the first-line agent when nitric oxide shows no effect. C. Add calcium channel blocker: Calcium channel blockers are typically used in select patients with pulmonary hypertension who show a positive response to vasodilator testing, typically with inhaled nitric oxide or other agents. However, since this patient showed no response to nitric oxide, using a calcium channel blocker would not be effective. These are generally reserved for vasoreactive pulmonary hypertension, which is not the case here. D. Add diuretics: Diuretics are important in the management of right heart failure or fluid overload in patients with pulmonary hypertension, but they do not treat the underlying pulmonary vascular resistance or elevated pulmonary artery pressures directly. This patient has pulmonary arterial hypertension that requires targeted pulmonary vasodilator therapy, such as epoprostenol.",
      "correct_choice_id": 219055,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34415561705050184/34415561705050184.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34415561705050184/34415561705050184.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}